Assessment of regulatory needs list

Assessment of regulatory needs list

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 13 September 2021. Database contains 268 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

The List does not contain any Substances.
 
204-126-9
116-14-3
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/12/2018
Details
203-726-8
109-99-9
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
203-625-9
108-88-3
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
Other
14/07/2020
Details
215-157-2
1308-06-1
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
234-829-6
12035-72-2
Hungary
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/05/2017
Details
237-158-7
13674-84-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
213-934-0
1067-53-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
13/06/2016
Details
237-159-2
13674-87-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
225-768-6
5064-31-3
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
-
-
Germany
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
17/01/2020
Details
203-545-4
108-05-4
Sweden
Carcinogenic
Mutagenic
Concluded
No need to initiate further regulatory risk management action at this time
None
17/12/2020
Details
203-293-5
105-38-4
Sweden
Carcinogenic
Mutagenic
Concluded
No need to initiate further regulatory risk management action at this time
None
17/12/2020
Details
215-535-7
1330-20-7
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
202-853-6
100-44-7
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
246-932-3
25387-93-3
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/09/2021
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
253-242-6
36861-47-9
Denmark
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
26/05/2021
Details
690-137-8
5436-43-1
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
Other
23/08/2019
Details
431-890-2
166412-78-8
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
15/03/2016
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
28/01/2020
Details
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
274-570-6
70321-86-7
Germany
Endocrine disruption
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
201-245-8
80-05-7
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
210-658-2
620-92-8
Sweden
Endocrine disruption
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
CLH
30/03/2021
Details
202-679-0
98-54-4
Germany
Endocrine disruption
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/10/2019
Details
677-811-7
207386-91-2
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/09/2021
Details
205-137-1
134-31-6
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/09/2021
Details
201-545-9
84-61-7
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/09/2015
Details
212-485-8
822-06-0
Germany
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
03/05/2019
Details
224-208-8
4247-02-3
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
19/01/2021
Details
247-421-8
26038-87-9
France
Endocrine disruption
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
201-280-9
80-46-6
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/03/2017
Details
231-512-4
7601-90-3
Germany
Endocrine disruption
Under development
Under development
No suggestion yet
13/06/2016
Details
show/hide
Dodecylphenol EC / List no: 248-312-8 | CAS no: 27193-86-8
p-dodecylphenol EC / List no: 203-202-9 | CAS no: 104-43-8
Phenol, dodecyl-, branched EC / List no: 310-154-3 | CAS no: 121158-58-5
Phenol, tetrapropylene- EC / List no: - | CAS no: 57427-55-1
Phenol, 4-isododecyl- EC / List no: - | CAS no: 27147-75-7
phenol, 4-dodecyl-, branched EC / List no: - | CAS no: 210555-94-5
Phenol, 4-isododecyl- EC / List no: 608-055-8 | CAS no: 27459-10-5
phenol, (tetrapropenyl) derivatives EC / List no: - | CAS no: 74499-35-7
-
-
Germany
Endocrine disruption
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
25/11/2020
Details
205-711-1
148-24-3
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/09/2021
Details
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
-
-
Austria
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
203-585-2
108-46-3
Finland
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/09/2019
Details
202-851-5
100-42-5
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/11/2014
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/03/2017
Details
246-563-8
25013-16-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Restriction
17/01/2019
Details
260-830-6
57583-54-7
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
201-071-2
77-94-1
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
22/01/2019
Details
201-067-0
77-90-7
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/11/2016
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.